Recent Posts »
Risk assessment key to address anti-corruption risk exposure
Canadian companies operating abroad would be well-advised to conduct comprehensive risk assessments to guard against anti-corruption risk exposure, recommends a recent post by John Boscariol on Lexology. “Canadian companies operating abroad can face particularly high
Read More »Logistics companies risk UK bribery prosecution
A number of the world’s biggest logistics companies are putting themselves and their customers at risk of prosecution under UK bribery laws, according to research by business ethics consultants GoodCorporation
Read More »Complying With The Foreign Corrupt Practices Act in African Transactions
U.S. companies are increasingly turning to African markets as desirable places to sell their products and services. However, as international business dealings continue to rise, so too does the risk of Foreign Corrupt
Read More »South Africa introduces aggressive new anti-corruption measures
Corruption in South Africa has reached staggering proportions. Daily newspapers are rife with reports of widespread corruption in both the public and private sectors. The arms deals scandal, coupled with prison sentences for the
Read More »Fighting Bribery and Corruption: Controlling the risk, limiting the damage
Organizations operating internationally need to be aware of bribery and corruption risks and have measures in place to curb their exposures. Laws and guidelines barring bribery of foreign officials, such as the U.S. Foreign
Read More »SFO Launches Criminal Bribery Probe Into EADS Unit
The U.K. Serious Fraud office said Thursday that it’s launching a criminal probe into allegations concerning a unit of European Aeronautic Defence & Space Co., or EADS, and its business in Saudi Arabia.
Read More »Pfizer DPA: New Minimum Best Practices for FCPA Compliance Programs?
Last week was wild in the Foreign Corrupt Practices Act (FCPA) and wider compliance world. In the FCPA arena, as most compliance practitioners are aware, Pfizer settled its FCPA enforcement action this week. In
Read More »Pfizer pays $60 million to settle bribery charges
Pfizer has agreed to pay the federal government $60 million to settle allegations that its employees bribed doctors and other foreign officials in Europe and Asia to win business and boost sales.
Read More »